Nectar Lifescience Ltd.
BSE: 532649 | Sector: Health care |
NSE: NECLIFE | ISIN Code: INE023H01027 |
BSE 14:27 | 24 Mar | 16.34 |
-0.21 (-1.27%) |
OPEN
16.60 |
HIGH
16.90 |
LOW
16.15 |
NSE 14:14 | 24 Mar | 16.30 |
-0.20 (-1.21%) |
OPEN
16.85 |
HIGH
16.85 |
LOW
16.20 |
OPEN | 16.60 |
PREVIOUS CLOSE | 16.55 |
VOLUME | 42450 |
52-Week high | 34.10 |
52-Week low | 15.89 |
P/E | |
Mkt Cap.(Rs cr) | 367 |
Buy Price | 16.25 |
Buy Qty | 200.00 |
Sell Price | 16.34 |
Sell Qty | 97.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Nectar Lifescience Ltd. (NECLIFE) - Financial Ratios
Ratios | 2022 | 2021 | 2020 |
Debt-Equity Ratio | 0.82 | 0.77 | 0.75 |
Current Ratio | 1.17 | 1.12 | 1.18 |
Asset turnover ratio | 1.23 | 1.15 | 1.76 |
Inventory turnover ratio | 3.09 | 2.26 | 2.79 |
Debtors turnover ratio | 4.69 | 4.57 | 5.51 |
Interest Coverage ratio | 1.32 | 0.47 | 1.28 |
Operating Margin (%) | 8.35 | 6.41 | 8.42 |
Net Profit Margin (%) | 0.83 | -2.71 | 1.14 |
Return on Capital Employed (%) | 5.28 | 2.71 | 8.17 |
Return on Net Worth (%) | 1.48 | -4.35 | 2.68 |
Quick Links for Nectar Lifescience:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices